Brief: Instil Bio Gets Clearance For Phase 2 Trial For Patients With Advanced Melanoma

Instil Bio

13/09/2021 13:53

Sept 13 (Reuters) - Instil Bio Inc  TIL.O :
    * INSTIL BIO RECEIVES IND CLEARANCE TO INITIATE A PHASE 2
CLINICAL
TRIAL FOR PATIENTS WITH ADVANCED MELANOMA
    * INSTIL BIO INC - TOPLINE SAFETY AND EFFICACY RESULTS ARE
EXPECTED IN 2023
    * INSTIL BIO INC -  TOPLINE SAFETY AND EFFICACY RESULTS, IF
POSITIVE, ARE ANTICIPATED TO SUPPORT SUBMISSION OF A BLA TO FDA
IN 2023
    * INSTIL BIO INC -TOPLINE SAFETY AND EFFICACY RESULTS, IF
POSITIVE, ARE ANTICIPATED TO SUPPORT SUBMISSION OF A MAA TO
EUROPEAN MEDICINES AGENCY IN 2024

Source text for Eikon:  ID:nGNXbNbylw 
Further company coverage:  TIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))